Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.310
-0.100 (-7.04%)
Nov 5, 2024, 11:13 AM EST - Market open

Barinthus Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
5214288388--
Market Cap Growth
-30.86%62.36%-77.38%---
Enterprise Value
-48-5-104162--
Last Close Price
1.453.692.3511.11--
PE Ratio
--1.9316.79-5.66--
PS Ratio
-177.441.961445.93--
PB Ratio
0.360.760.361.53--
P/FCF Ratio
-0.99-2.53-4.26-11.49--
P/OCF Ratio
-1.00-2.79-6.07-11.89--
EV/Sales Ratio
--6.35-2.32605.57--
EV/EBITDA Ratio
0.950.0759.33-3.98--
EV/EBIT Ratio
0.910.0636.15-3.94--
EV/FCF Ratio
1.130.095.05-4.81--
Debt / Equity Ratio
0.080.070.040.03-14.730.15
Debt / FCF Ratio
-0.23-0.23-0.43-0.21-4.10-0.09
Asset Turnover
-0.000.160.000.14-
Quick Ratio
7.9211.9116.8719.816.122.67
Current Ratio
8.4612.4517.4020.326.272.83
Return on Equity (ROE)
-34.13%-34.15%2.15%-40.99%-420.05%-
Return on Assets (ROA)
-19.70%-20.73%-0.65%-15.55%-30.07%-
Return on Capital (ROIC)
-21.37%-22.24%-0.70%-17.00%-36.98%-
Earnings Yield
-111.87%-51.54%6.09%-13.13%--
FCF Yield
-96.47%-39.59%-23.47%-8.70%--
Buyback Yield / Dilution
-2.59%-0.57%-47.40%-227.59%-33580.72%-
Total Shareholder Return
-2.59%-0.57%-47.40%-227.59%-33580.72%-
Source: S&P Capital IQ. Standard template. Financial Sources.